Impax Laboratories Inc. (NASDAQ:IPXL)
| CAPS Rating |
|
|---|---|
| Open | $21.54 |
| Previous Close | $21.75 |
| Daily Range | $21.41 - $22.00 |
| 52-Week Range | $14.46 - $28.75 |
| Market Cap | $1.44B |
| P/E Ratio | 11.40 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 579,474 |
| Average Daily Volume | 0 |
IPXL
VS S&P 500 (SPY)
How do you think IPXL will perform against the market?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
IPXL Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
IPXL News and Commentary
- Shire and Sangamo Cut a Deal - Analyst Blog – NASDAQ
- Impax Gains Rights For US Sales Of Zomig; Paying $130 Million In 2012 – SmartMoney
- Perrigo Files for Generic Astepro - Analyst Blog – NASDAQ
- Shire, Prasco Ink Deal - Analyst Blog – NASDAQ
- Covidien Spins Off Drug Company: 5 Drug Makers Hedge Funds Want Most – NASDAQ
- Covidien Spins Off Drug Company: 5 Drug Makers Hedge Funds Want Most – The Motley Fool
- The New Pfizer: 6 Drug Companies with Bullish Short Trends – NASDAQ
- The New Pfizer: 6 Drug Companies With Bullish Short Trends – The Motley Fool
- Checking an Important, Overlooked Metric at Abbott Labs – The Motley Fool
- Abbott Laboratories Passes This Key Test – The Motley Fool
- 1 Reason the Street Should Love Abbott Laboratories' Earnings – The Motley Fool
- Here's How Abbott Laboratories Is Making You So Much Cash – The Motley Fool
- Is Optimer Pharmaceuticals the Perfect Stock? – The Motley Fool
- Will Impax Laboratories Disappoint Analysts Next Quarter? – The Motley Fool
- Is Abbott Laboratories' Cash Machine Slowing Down? – The Motley Fool
- GSK Sues to Block Generic BPH Drugs From Mylan, Impax – The Motley Fool
- 12 Pharmaceutical Stocks the Insiders Are Buying – The Motley Fool
- US Indexes Remain Higher Into Session's Half Despite Weak Manufacturing Data; Commodities Higher – NASDAQ
- Mid-Day Update: Stocks Green Despite Weak Manufacturing Data; Commodities Rise – NASDAQ
- Abbott Picks Pumps Over Pills – The Motley Fool
RSS Headlines
Fool UK
